Literature DB >> 17012912

A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa.

Eleni Yiasemides1, Judie Walton, Penelope Marr, Elmer V Villanueva, Dédée F Murrell.   

Abstract

The classification of epidermolysis bullosa (EB) into 3 main subtypes has been based on transmission electron microscopy (TEM) that is able to directly visualize and quantify specific ultrastructural features. Immunofluorescence antigenic mapping (IFM) is a technique that determines the precise level of skin cleavage by determining binding sites for a series of antibodies. To date, no study has compared the accuracy of these two techniques in diagnosing the major types of EB. A prospective cohort of 33 patients thought to have EB on clinical grounds had TEM, IFM, and genetic testing performed. The sensitivities and specificities of TEM and IFM were calculated compared with the genetic results. Of 33 cases, 30 had a positive EB diagnosis. TEM subclassified EB into its three major forms in 24/30 cases (80%) and IFM in 29/30 cases (97%). Overall, TEM sensitivities and specificities when compared with genetic results were 71% and 81%, respectively. IFM sensitivities and specificities when compared with genetic results were 97% and 100%, respectively. If a patient tested positive for EB by IFM, the likelihood ratio of having a particular type of EB was consistently greater than 20 against the reference standard (compared with a likelihood ratio less than 10 for TEM). Our results indicate that the diagnosis of EB is improved (sometimes substantially) by the use of IFM compared with TEM.

Entities:  

Mesh:

Year:  2006        PMID: 17012912     DOI: 10.1097/01.dad.0000211510.44865.6d

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

1.  Epidermolysis bullosae.

Authors:  A N Prasad
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita.

Authors:  S R Humphrey; X Hu; K Adamson; A Schaus; J N Jensen; B Drolet
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

Review 3.  Integrated Management Strategies for Epidermolysis Bullosa: Current Insights.

Authors:  Haseena Sait; Somya Srivastava; Deepti Saxena
Journal:  Int J Gen Med       Date:  2022-05-24

4.  Diagnostic pitfalls in newborns and babies with blisters and erosions.

Authors:  Elke Nischler; Alfred Klausegger; Clemens Hüttner; Gabriele Pohla-Gubo; Anja Diem; Johann W Bauer; Helmut Hintner
Journal:  Dermatol Res Pract       Date:  2010-01-20

5.  Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa.

Authors:  Marilina Tampoia; Domenico Bonamonte; Angela Filoni; Lucrezia Garofalo; Maria Grazia Morgese; Luigia Brunetti; Chiara Di Giorgio; Giuseppina Annicchiarico
Journal:  Orphanet J Rare Dis       Date:  2013-09-04       Impact factor: 4.123

6.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

7.  Gene panel for the diagnosis of epidermolysis bullosa: proposal for a viable and efficient approach.

Authors:  Luiza Monteavaro Mariath; Ana Elisa Kiszewski; Jeanine Aparecida Frantz; Marina Siebert; Ursula Matte; Lavínia Schuler-Faccini
Journal:  An Bras Dermatol       Date:  2021-02-02       Impact factor: 1.896

8.  Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa.

Authors:  Raghavendra Rao; Varsha M Shetty
Journal:  Indian J Dermatol       Date:  2021 Jul-Aug       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.